NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ: NNNN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$28.50
+3.90% today
Updated 2026-04-30
Market cap
$1.20B
P/E ratio
182.87
P/S ratio
139.23x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$6 – $56
Volume
0.0M
Anbio Biotechnology Class A Ordinary Shares (NNNN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
74.10%
Operating margin
59.10%
ROE
27.10%
ROA
14.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $4.43M | $2.54M | 57.40% | 55.46% | 57.26% |
| 2022 | $23.54M | $10.01M | 53.36% | 43.30% | 42.52% |
| 2023 | $6.71M | $2.25M | 50.07% | 29.22% | 33.58% |
| 2024 | $8.19M | $2.37M | 71.90% | 24.38% | 28.99% |
| 2025 | $8.65M | $6.40M | 87.24% | 66.70% | 74.06% |